Skip to content

Study on the Construction of Cardiovascular Risk Assessment System for Acute Myocardial Infarction Patients After PCI Based on the Determination of Oxygen Free Radical Expression

Study on the Construction of Cardiovascular Risk Assessment System for Acute Myocardial Infarction Patients After PCI Based on the Determination of Oxygen Free Radical Expression

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109198
Enrollment
Unknown
Registered
2025-09-15
Start date
2025-09-15
Completion date
Unknown
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction (AMI)

Interventions

Reactive Oxygen Species (ROS) High-Level Group (Group T3):None
Reactive Oxygen Species (ROS) Medium-Level Group (Group T2):None
Reactive Oxygen Species (ROS) Low-Level Group (Group T1):None

Sponsors

The First Hospital Of Jiaxing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years old; 2. Diagnosed with Acute Myocardial Infarction (AMI) and treated with Percutaneous Coronary Intervention (PCI); 3. Informed consent signed by the patient or their legal representative.

Exclusion criteria

Exclusion criteria: 1. Complicated with other severe cardiovascular diseases such as cardiomyopathy and valvular heart disease; 2. Severe hepatic and renal insufficiency (ALT/AST > 3 times the upper limit of normal, creatinine clearance < 30 ml/min); 3. A history of major surgery or trauma within the past 6 months, or malignant tumor (with an expected survival time < 1 year); 4. Inability to cooperate with follow-up, or presence of mental illness and cognitive impairment; 5. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Major Adverse Cardiovascular Events (MACE: reinfarction, heart failure, stroke, cardiogenic death);Reactive Oxygen Species (ROS) Level (including O2-, H2O2) , Cellular Metabolic Activity (CMA) Indicators (protein synthesis efficiency, ATP production rate, enzyme catalytic activity);

Secondary

MeasureTime frame
Minor Adverse Cardiovascular Events (angina pectoris, coronary slow flow/no-reflow);

Countries

China

Contacts

Public ContactZhai Changlin

The First Hospital Of Jiaxing

yesterdaygun@126.com+86 573 8251 9988

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026